MSR1 and neoplasm: Using either 5-(tetradecycloxy)-2-furoic acid (TOFA), an inhibitor of acetyl-CoA carboxylase (ACC) that participates in fatty acid synthesis, or neutralizing antibodies to MSR1 before the incubation of DCs with tumor supernatant, substantially enhanced the anti-tumor potency of DCs vaccination [173].